{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T02:44:14Z","timestamp":1783824254882,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract\n<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Steatotic liver disease (SLD) is the most prevalent chronic liver disease worldwide and linked to various liver and extrahepatic diseases. However, the clustering of extrahepatic conditions and their impact on mortality in individuals with SLD remain poorly understood.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We used UK Biobank data to identify sex-specific disease clusters among individuals with SLD and multimorbidity (having\u2009\u2265\u20092 extrahepatic diseases) using latent class analysis. Multivariable Cox models were used to assess associations between multimorbidity, disease clusters and all-cause mortality and mortality from cardiovascular diseases (CVD), extrahepatic cancers, liver-related diseases and hepatocellular carcinoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among 178,336 (36.3% female) individuals with SLD, during a median follow-up of 13.8 years, multimorbidity increased mortality by 100% (hazard ratio (95% confidence interval): 2.00 (1.93, 2.08)) and 80% (1.80 (1.71, 1.90)) in males and females, respectively, and increased the risk of death from CVD, extrahepatic cancers and liver-related diseases. Among 36,002 (43.9% female) of the 178,336 with multimorbidity, we identified five disease clusters in both sexes: related to respiratory, mental health, cancer\/osteoarthritis and cardiovascular diseases. Males had separate heart and stroke clusters, whereas females had a combined heart\/stroke cluster and a unique thyroid cluster. CVD was the leading cause of death in cardiovascular clusters, whereas extrahepatic cancers were the most common cause of death in other clusters. Among all disease clusters, cardiovascular clusters exhibited the highest all-cause mortality risk: 2.90 (2.64, 3.20) for the heart\/stroke cluster in females and 2.63 (2.48, 2.78) for the heart cluster and 2.36 (2.16, 2.58) for the stroke cluster in males. All clusters exhibited increased mortality of CVD and extrahepatic cancers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Multimorbidity doubled the death rate in people with SLD. Common multimorbidity clusters of mental health, respiratory, cancer and cardiovascular diseases were found and were associated with varying mortality, with cardiovascular-related clusters showing the highest risk. Females exhibited a unique thyroid disease cluster. These findings highlight the need for tailored prevention and management strategies in SLD populations.\n<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12916-025-04288-4","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T13:50:24Z","timestamp":1753969824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Extrahepatic disease clusters and mortality in people with steatotic liver diseases: a prospective analysis of 64,749 females and 113,587 males in the UK Biobank"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9323-9421","authenticated-orcid":false,"given":"Qi","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chioma N.","family":"Izzi-Engbeaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Beaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinelopi","family":"Manousou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"issue":"9","key":"4288_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851\u201361.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10290","key":"4288_CR2","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VWS, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212\u201324.","journal-title":"Lancet"},{"issue":"10464","key":"4288_CR3","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","volume":"404","author":"M Israelsen","year":"2024","unstructured":"Israelsen M, Francque S, Tsochatzis EA, Krag A. Steatotic liver disease. Lancet. 2024;404(10464):1761\u201378.","journal-title":"Lancet"},{"issue":"1","key":"4288_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13098-020-00570-y","volume":"12","author":"AF Godoy-Matos","year":"2020","unstructured":"Godoy-Matos AF, Silva J\u00fanior WS, Valerio CM. Nafld as a continuum: from obesity to metabolic syndrome and diabetes. Diabetol Metab Syndr. 2020;12(1):60.","journal-title":"Diabetol Metab Syndr"},{"issue":"7","key":"4288_CR5","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","volume":"110","author":"P Kasper","year":"2021","unstructured":"Kasper P, Martin A, Lang S, K\u00fctting F, Goeser T, Demir M, et al. NAFLD and cardiovascular diseases: a clinical review. Clin Res Cardiol. 2021;110(7):921\u201337.","journal-title":"Clin Res Cardiol"},{"issue":"7","key":"4288_CR6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nrgastro.2012.79","volume":"9","author":"E Bonora","year":"2012","unstructured":"Bonora E, Targher G. Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. Nat Rev Gastroenterol Hepatol. 2012;9(7):372\u201381.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"4288_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S2468-1253(23)00275-3","volume":"9","author":"JA Thomas","year":"2024","unstructured":"Thomas JA, Kendall BJ, El-Serag HB, Thrift AP, Macdonald GA. Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease. Lancet Gastroenterol Hepatol. 2024;9(2):159\u201369.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4288_CR8","unstructured":"The Academy of medical Research. Multimorbidity: a priority for global health research. 2018. Available from: https:\/\/acmedsci.ac.uk\/file-download\/82222577 . Cited 2024 May 8."},{"issue":"1","key":"4288_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41572-022-00376-4","volume":"8","author":"ST Skou","year":"2022","unstructured":"Skou ST, Mair FS, Fortin M, Guthrie B, Nunes BP, Miranda JJ, et al. Multimorbidity. Nat Rev Dis Primers. 2022;8(1):48.","journal-title":"Nat Rev Dis Primers"},{"issue":"7800","key":"4288_CR10","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/d41586-020-00837-4","volume":"579","author":"CJM Whitty","year":"2020","unstructured":"Whitty CJM, Watt FM. Map clusters of diseases to tackle multimorbidity. Nature. 2020;579(7800):494\u20136.","journal-title":"Nature"},{"issue":"9","key":"4288_CR11","doi-asserted-by":"publisher","first-page":"e2232124","DOI":"10.1001\/jamanetworkopen.2022.32124","volume":"5","author":"CM Calvin","year":"2022","unstructured":"Calvin CM, Conroy MC, Moore SF, Ku\u017ama E, Littlejohns TJ. Association of multimorbidity, disease clusters, and modification by genetic factors with risk of dementia. JAMA Netw Open. 2022;5(9):e2232124.","journal-title":"JAMA Netw Open"},{"key":"4288_CR12","doi-asserted-by":"publisher","first-page":"102703","DOI":"10.1016\/j.eclinm.2024.102703","volume":"74","author":"SJ Krauth","year":"2024","unstructured":"Krauth SJ, Steell L, Ahmed S, McIntosh E, Dibben GO, Hanlon P, et al. Association of latent class analysis-derived multimorbidity clusters with adverse health outcomes in patients with multiple long-term conditions: comparative results across three UK cohorts. eClinicalMedicine. 2024;74:102703.","journal-title":"eClinicalMedicine"},{"issue":"1","key":"4288_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6(1):33.","journal-title":"BMC Gastroenterol"},{"key":"4288_CR14","doi-asserted-by":"publisher","first-page":"204062232211224","DOI":"10.1177\/20406223221122478","volume":"13","author":"W Ma","year":"2022","unstructured":"Ma W, Wu W, Wen W, Xu F, Han D, Lyu J, et al. Association of NAFLD with cardiovascular disease and all-cause mortality: a large-scale prospective cohort study based on UK Biobank. Ther Adv Chronic Dis. 2022;13:204062232211224.","journal-title":"Ther Adv Chronic Dis"},{"issue":"12","key":"4288_CR15","doi-asserted-by":"publisher","first-page":"100896","DOI":"10.1016\/j.jhepr.2023.100896","volume":"5","author":"B Ho","year":"2023","unstructured":"Ho B, Thompson A, Jorgensen AL, Pirmohamed M. Role of fatty liver index in risk-stratifying comorbid disease outcomes in non-alcoholic fatty liver disease. JHEP Rep. 2023;5(12):100896.","journal-title":"JHEP Rep"},{"issue":"6","key":"4288_CR16","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356.","journal-title":"J Hepatol"},{"issue":"1","key":"4288_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2022-000247","volume":"1","author":"ISS Ho","year":"2022","unstructured":"Ho ISS, Azcoaga-Lorenzo A, Akbari A, Davies J, Khunti K, Kadam UT, et al. Measuring multimorbidity in research: delphi consensus study. BMJ Med. 2022;1(1): e000247.","journal-title":"BMJ Med"},{"issue":"4","key":"4288_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1177\/0095798420930932","volume":"46","author":"BE Weller","year":"2020","unstructured":"Weller BE, Bowen NK, Faubert SJ. Latent class analysis: a guide to best practice. J Black Psychol. 2020;46(4):287\u2013311.","journal-title":"J Black Psychol"},{"issue":"24","key":"4288_CR19","doi-asserted-by":"publisher","first-page":"9805","DOI":"10.18632\/aging.204395","volume":"14","author":"A Roso-Llorach","year":"2022","unstructured":"Roso-Llorach A, Vetrano DL, Trevisan C, Fern\u00e1ndez S, Guisado-Clavero M, Carrasco-Ribelles LA, et al. 12-year evolution of multimorbidity patterns among older adults based on hidden Markov models. Aging (Albany NY). 2022;14(24):9805\u201317.","journal-title":"Aging (Albany NY)"},{"key":"4288_CR20","doi-asserted-by":"crossref","unstructured":"Issa G, Shang Y, Strandberg R, Hagstr\u00f6m H, Wester A. Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden. J Hepatol. 2025;S0168-8278(25)00156-4.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/40139508\/.","DOI":"10.1016\/j.jhep.2025.03.001"},{"issue":"7","key":"4288_CR21","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","volume":"70","author":"TG Simon","year":"2021","unstructured":"Simon TG, Roelstraete B, Khalili H, Hagstr\u00f6m H, Ludvigsson JF. Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort. Gut. 2021;70(7):1375\u201382.","journal-title":"Gut"},{"issue":"1","key":"4288_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02716-3","volume":"21","author":"GE Chung","year":"2023","unstructured":"Chung GE, Yu SJ, Yoo JJ, Cho Y, Lee KN, Shin DW, et al. Lean or diabetic subtypes predict increased all-cause and disease-specific mortality in metabolic-associated fatty liver disease. BMC Med. 2023;21(1): 4.","journal-title":"BMC Med"},{"issue":"3","key":"4288_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aay5034","volume":"6","author":"A Thompson","year":"2020","unstructured":"Thompson A, Cook J, Choquet H, Jorgenson E, Yin J, Kinnunen T, et al. Functional validity, role, and implications of heavy alcohol consumption genetic loci. Sci Adv. 2020;6(3): eaay5034.","journal-title":"Sci Adv"},{"key":"4288_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2023.11.004","volume":"165","author":"TB Dhafari","year":"2024","unstructured":"Dhafari TB, Pate A, Azadbakht N, Bailey R, Rafferty J, Jalali-najafabadi F, et al. A scoping review finds a growing trend in studies validating multimorbidity patterns and identifies five broad types of validation methods. J Clin Epidemiol. 2024;165: 111214.","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"4288_CR25","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s10654-019-00568-5","volume":"34","author":"L Busija","year":"2019","unstructured":"Busija L, Lim K, Szoeke C, Sanders KM, McCabe MP. Do replicable profiles of multimorbidity exist? Systematic review and synthesis. Eur J Epidemiol. 2019;34(11):1025\u201353.","journal-title":"Eur J Epidemiol"},{"key":"4288_CR26","doi-asserted-by":"publisher","first-page":"100047","DOI":"10.1016\/j.lanepe.2021.100047","volume":"3","author":"A Bisquera","year":"2021","unstructured":"Bisquera A, Gulliford M, Dodhia H, Ledwaba-Chapman L, Durbaba S, Soley-Bori M, et al. Identifying longitudinal clusters of multimorbidity in an urban setting: a population-based cross-sectional study. The Lancet Regional Health - Europe. 2021;3:100047.","journal-title":"The Lancet Regional Health - Europe"},{"issue":"6","key":"4288_CR27","doi-asserted-by":"publisher","first-page":"bbac410","DOI":"10.1093\/bib\/bbac410","volume":"23","author":"B Prasad","year":"2022","unstructured":"Prasad B, Bjourson AJ, Shukla P. Data-driven patient stratification of UK Biobank cohort suggests five endotypes of multimorbidity. Brief Bioinform. 2022;23(6):bbac410.","journal-title":"Brief Bioinform"},{"issue":"1","key":"4288_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12877-018-0705-7","volume":"18","author":"M Guisado-Clavero","year":"2018","unstructured":"Guisado-Clavero M, Roso-Llorach A, L\u00f3pez-Jimenez T, Pons-Vigu\u00e9s M, Foguet-Boreu Q, Mu\u00f1oz MA, et al. Multimorbidity patterns in the elderly: a prospective cohort study with cluster analysis. BMC Geriatr. 2018;18(1):16.","journal-title":"BMC Geriatr"},{"issue":"12","key":"4288_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0295958","volume":"18","author":"G Nazar","year":"2023","unstructured":"Nazar G, D\u00edaz-Toro F, Concha-Cisternas Y, Leiva-Ordo\u00f1ez AM, Troncoso-Pantoja C, Celis-Morales C, et al. Latent class analyses of multimorbidity and all-cause mortality: a prospective study in Chilean adults. PLoS One. 2023;18(12): e0295958.","journal-title":"PLoS One"},{"key":"4288_CR30","doi-asserted-by":"crossref","unstructured":"He K, Zhang W, Hu X, Zhao H, Guo B, Shi Z, et al. Relationship between multimorbidity, disease cluster and all-cause mortality among older adults: a retrospective cohort analysis. BMC Public Health. 2021;21(1). Available from: https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-11108-w.","DOI":"10.1186\/s12889-021-11108-w"},{"issue":"12","key":"4288_CR31","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1093\/rheumatology\/keaa166","volume":"59","author":"MM Ward","year":"2020","unstructured":"Ward MM, Alehashemi S. Risks of solid cancers in elderly persons with osteoarthritis or ankylosing spondylitis. Rheumatology (Oxford). 2020;59(12):3817\u201325.","journal-title":"Rheumatology (Oxford)"},{"key":"4288_CR32","doi-asserted-by":"publisher","first-page":"100768","DOI":"10.1016\/j.lanepe.2023.100768","volume":"35","author":"M Beydon","year":"2023","unstructured":"Beydon M, Pinto S, De Rycke Y, Fautrel B, Mariette X, Seror R, et al. Risk of cancer for patients with rheumatoid arthritis versus general population: a national claims database cohort study. The Lancet Regional Health - Europe. 2023;35:100768.","journal-title":"The Lancet Regional Health - Europe"},{"issue":"6","key":"4288_CR33","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1093\/rheumatology\/keab733","volume":"61","author":"A Turkiewicz","year":"2022","unstructured":"Turkiewicz A, D\u00edaz Y, Duarte-Salles T, Prieto-Alhambra D. Knee and hip osteoarthritis and risk of nine cancers in a large real-world matched cohort study. Rheumatology. 2022;61(6):2325\u201334.","journal-title":"Rheumatology"},{"issue":"1","key":"4288_CR34","doi-asserted-by":"publisher","first-page":"e6829","DOI":"10.1002\/cam4.6829","volume":"13","author":"X Zhang","year":"2024","unstructured":"Zhang X, Wen Z, Xing Z, Zhou X, Yang Z, Dong R, et al. The causal relationship between osteoarthritis and bladder cancer: a Mendelian randomization study. Cancer Med. 2024;13(1):e6829.","journal-title":"Cancer Med"},{"issue":"1","key":"4288_CR35","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1186\/s12967-024-05765-9","volume":"22","author":"C Meisinger","year":"2024","unstructured":"Meisinger C, Fischer S, O\u2019Mara T, Freuer D. Two-sample Mendelian randomization to evaluate the causal relationship between inflammatory arthritis and female-specific cancers. J Transl Med. 2024;22(1):962.","journal-title":"J Transl Med"},{"issue":"25","key":"4288_CR36","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"key":"4288_CR37","unstructured":"Chong B, Jayabaskaran J, Jauhari SM, Chan SP, Goh R, Kueh MTW, et al. Global burden of cardiovascular diseases: projections from 2025 to 2050. Eur J Prev Cardiol. 2024:zwae281.\u00a0https:\/\/academic.oup.com\/eurjpc\/advance-article-abstract\/doi\/10.1093\/eurjpc\/zwae281\/7756567?redirectedFrom=fulltext&login=false"},{"issue":"6","key":"4288_CR38","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1136\/heartjnl-2020-317446","volume":"107","author":"AC Pinho-Gomes","year":"2021","unstructured":"Pinho-Gomes AC, Peters SAE, Thomson B, Woodward M. Sex differences in prevalence, treatment and control of cardiovascular risk factors in England. Heart. 2021;107(6):462\u20137.","journal-title":"Heart"},{"issue":"5","key":"4288_CR39","first-page":"699","volume":"37","author":"PJ Connelly","year":"2021","unstructured":"Connelly PJ, Azizi Z, Alipour P, Delles C, Pilote L, Raparelli V. The importance of gender to understand sex differences in cardiovascular disease. Can J Cardiol. 2021;37(5):699\u2013710.","journal-title":"Can J Cardiol"},{"issue":"2","key":"4288_CR40","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/wps.21073","volume":"22","author":"ND Volkow","year":"2023","unstructured":"Volkow ND, Blanco C. Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. World Psychiatry. 2023;22(2):203\u201329.","journal-title":"World Psychiatry"},{"issue":"1","key":"4288_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/bmb\/ldr030","volume":"99","author":"MPJ Vanderpump","year":"2011","unstructured":"Vanderpump MPJ. The epidemiology of thyroid disease. Br Med Bull. 2011;99(1):39\u201351.","journal-title":"Br Med Bull"},{"issue":"5","key":"4288_CR42","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00127-018-1644-5","volume":"54","author":"K Alvarez","year":"2019","unstructured":"Alvarez K, Fillbrunn M, Green JG, Jackson JS, Kessler RC, McLaughlin KA, et al. Race\/ethnicity, nativity, and lifetime risk of mental disorders in US adults. Soc Psychiatry Psychiatr Epidemiol. 2019;54(5):553\u201365.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"4288_CR43","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jad.2024.05.026","volume":"358","author":"P Irizar","year":"2024","unstructured":"Irizar P, Taylor H, Kapadia D, Pierce M, B\u00e9cares L, Goodwin L, et al. The prevalence of common mental disorders across 18 ethnic groups in Britain during the COVID-19 pandemic: evidence for equality national survey (EVENS). J Affect Disord. 2024;358:42\u201351.","journal-title":"J Affect Disord"},{"issue":"12","key":"4288_CR44","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/s41416-022-01718-5","volume":"126","author":"C Delon","year":"2022","unstructured":"Delon C, Brown KF, Payne NWS, Kotrotsios Y, Vernon S, Shelton J. Differences in cancer incidence by broad ethnic group in England, 2013\u20132017. Br J Cancer. 2022;126(12):1765\u201373.","journal-title":"Br J Cancer"},{"key":"4288_CR45","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.archger.2016.07.008","volume":"67","author":"BP Nunes","year":"2016","unstructured":"Nunes BP, Flores TR, Mielke GI, Thum\u00e9 E, Facchini LA. Multimorbidity and mortality in older adults: a systematic review and meta-analysis. Arch Gerontol Geriatr. 2016;67:130\u20138.","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"4288_CR46","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1186\/s12889-023-16202-9","volume":"23","author":"MC Conroy","year":"2023","unstructured":"Conroy MC, Reeves GK, Allen NE. Multi-morbidity and its association with common cancer diagnoses: a UK Biobank prospective study. BMC Public Health. 2023;23(1):1300.","journal-title":"BMC Public Health"},{"key":"4288_CR47","doi-asserted-by":"crossref","unstructured":"Hong SN, Lai FTT, Wang B, Choi EPH, Wong ICK, Lam CLK, et al. Age-specific multimorbidity patterns and burden on all-cause mortality and public direct medical expenditure: a retrospective cohort study. J Epidemiol Glob Health. 2024. Available from: https:\/\/link.springer.com\/10.1007\/s44197-024-00256-y. Cited 2024 Sep 17.","DOI":"10.1007\/s44197-024-00256-y"},{"issue":"5","key":"4288_CR48","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.joca.2021.12.013","volume":"30","author":"S Swain","year":"2022","unstructured":"Swain S, Coupland C, Strauss V, Mallen C, Kuo CF, Sarmanova A, et al. Clustering of comorbidities and associated outcomes in people with osteoarthritis - a UK clinical practice research datalink study. Osteoarthritis Cartilage. 2022;30(5):702\u201313.","journal-title":"Osteoarthritis Cartilage"},{"key":"4288_CR49","doi-asserted-by":"crossref","unstructured":"Feng Q, Izzi-Engbeaya CN, Branch AD, Mullish BH, Manousou P, Woodward M. The relationships between MASLD, extrahepatic multimorbidity and all-cause mortality in UK Biobank cohort. J Clin Endocrinol Metabol. 2025:dgaf342.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/40493745\/","DOI":"10.1101\/2025.03.09.25323328"},{"key":"4288_CR50","doi-asserted-by":"crossref","unstructured":"Feng Q, Izzi-Engbeaya C, Manousou P, Woodward M. Fibrosis status, extra-hepatic multimorbidity and all-cause mortality in 53093 women and 74377 men with MASLD in UK Biobank. BMC Gastroenterol. 2025. Available from: http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2025.03.09.25323329. Cited 2025 Mar 17.","DOI":"10.1101\/2025.03.09.25323329"},{"issue":"9","key":"4288_CR51","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, et al. Comparison of sociodemographic and health-related characteristics of UK biobank participants with those of the general population. Am J Epidemiol. 2017;186(9):1026\u201334.","journal-title":"Am J Epidemiol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04288-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04288-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04288-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T11:24:46Z","timestamp":1757330686000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-04288-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4288"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04288-4","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"1 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"UK Biobank received ethical approval from the National Information Governance Board for Health and Social Care and the National Health Service North West Multi-centre Centre for Research Ethics Committee (Ref: 21\/NW\/0157). All participants provided informed consent at recruitment to the study for their data to be used for health-related research that was in the public interest.UK Biobank has approval from the North West Multi-centre Research Ethics Committee as a Research Tissue Bank approval. This approval means that researchers do not require separate ethical clearance.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved this manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"450"}}